Fisher Price toy for babies and toddlers has been recalled over safety fears
Don't miss out on the headlines from Kids. Followed categories will be added to My News.
A Fisher Price toy designed for babies and toddlers has been recalled due to a serious risk of causing injury or death by choking.
The Fisher-Price 3-in-1 SnugaPuppy Activity Centre has been recalled due to fears the detachable tissue box attached to the toy can come apart, exposing the small support brackets to young children.
The Fisher-Price®3-in-1 SnugaPuppy™ Activity Center has been recalled due to fears the detachable tissue box toy can come apart
The Australian Competition and Consumer Commission (ACCC) have advised anyone who owns the toy to remove the tissue box toy from the activity centre immediately and place it out of reach of children.
There have been two reports worldwide of the tissue box toy coming apart, according to the ACCC.
No incidents have occurred in Australia and no injuries have been reported.
The SnugaPuppy was sold in Australia between December 2022 and September 2023.
It was available for purchase online and in stores at Catch, Kmart and Target.
Fisher Price is owned by manufacturing company Mattel, and the ACCC have advised anyone seeking information on how to return the tissue box component and receive a free replacement for the activity centre to get in touch with their customer service team.
The SnugaPuppy was sold in Australia between December 2022 and September 2023. It was available for purchase online and in stores at Catch, Kmart and Target.
The toy is described as having 'three ways to play as your child grows', and was advertised as suitable for newborns, babies and toddlers.
'The soft play mat gives newborns space to stretch, while the spinning seat gives babies all-around access to a variety of sensory toys and activities, including a light-up xylophone with 20 minutes of music! As they grow, toddlers can stand and explore all their favourite activities around the table,' the product description outlines.
Originally published as Fisher Price toy for babies and toddlers has been recalled over safety fears
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
7NEWS
05-06-2025
- 7NEWS
Australian breakthrough blood test offers hope for early ovarian cancer detection
An Australian developed blood test for cancer is being hailed as a potential lifesaver for thousands of women, with promising results unveiled at a major international medical conference. In a groundbreaking announcement at the American Society of Clinical Oncology (ASCO) conference in the United States, Australian scientists revealed the revolutionary blood test can detect ovarian cancer in its earliest-and most treatable-stages. Developed in a Melbourne laboratory, the INNOVIQ EXO-OC™ Test has shown remarkable accuracy in trials. Its key highlights include: 77 per cent sensitivity at 99.6 per cent specificity for detecting ovarian cancer across all stages, surpassing globally accepted clinical performance criteria for population screening. Detected all early-stage cancers (Stage I and II) with no missed diagnoses-a critical advancement in addressing the unmet need for accurate and reliable early detection in asymptomatic, average-risk women. 'This will be a world-first,' Dr Leearne Hinch, the CEO of the company told 7NEWS. 'Our test will enable many women's lives to be saved globally.' Professor Greg Rice, from the University of Queensland, who played a key role in the development of the test, confirmed the breakthrough. 'In the most recent tests that we completed, the EXO-OC™ test correctly identified all early stage ovarian cancers,' he told 7NEWS. Ovarian cancer is often called the 'silent killer' as it is usually asymptomatic in the early stages of disease. For women like Emily Jol, the test could have made a life-changing difference. It took six months for her to receive a diagnosis after being told an ovarian cyst found during a routine ultrasound was 'completely normal.' 'There was nothing wrong with it, they said. It was just part of being a woman,' Emily recalled to 7NEWS. Just 21-years-old at the time, she continued to push for answers and eventually, surgery revealed the truth: she had ovarian cancer. Fortunately, it was caught before it spread. 'I still consider myself to be really, really lucky,' she said. That's a rare outcome as currently, most ovarian cancer cases are diagnosed too late. One Australian woman dies from the disease every eight hours. Because it's often diagnosed at a late stage, after symptoms have appeared, the survival rate beyond five years can be as little as 30 per cent. But with the new test, scientists believe that survival rate could soar to over 90 percent. 'We're very proud that this is Australian science,' said Dr Hinch. The test is still undergoing further evaluation, but if all goes well, it could receive regulatory, FDA, approval in the United States soon, and hit the global market within two to three years. A message of hope where little existed before. It was partly funded by the Ovarian Cancer Research Foundation.
News.com.au
29-05-2025
- News.com.au
Thermomix cops massive ACCC fine after ‘misleading' NDIS approval claims
A massive kitchenware company allegedly falsely claimed its products were 'NDIS approved' to drive sales but has copped a massive fine instead. Vorwerk Australia, trading as Thermomix in Australia, has been fined nearly $80,000 for allegedly falsely suggesting two of its household appliances were endorsed by the National Disability Insurance Scheme. Thermomix falsely promoted the Thermomix TM6 cooking product and Kobold cordless vacuum and mop as being endorsed through the NDIS or registered by an entity administering the NDIS, the ACCC alleges. The Thermomix website in November last year and March this year allegedly described the two products as 'NDIS approved', 'NDIS-registered product', 'NDIS-consumables', 'NDIS assistive technology' and 'NDIS equipment'. However, the NDIS does not approve goods, according to ACCC chair Gina Cass-Gottlieb. 'The NDIS does not provide specific approval for any particular goods or services. Each NDIS participant has unique needs, and what's funded under their plan is determined individually, not through a list of approved products,' she said. 'There are no categories of goods or services which are automatically NDIS approved or funded for all NDIS participants. 'Misleading consumers experiencing vulnerability or disadvantage is of concern to us, and we will not hesitate to take appropriate action.' The ACCC put businesses on notice of problematic advertising targeting NDIS participants in November 2023. Just last week, bedding retailer Bedshed was fined nearly $40,000 for allegedly making similar false statements that some of its products were 'NDIS approved'.
News.com.au
13-05-2025
- News.com.au
Kmart, Target urgently recall popular Anko product Heated Elbow Pad
A popular heat wrap sold at Kmart and Target stores across Australia has been urgently recalled over safety fears. The Anko Heated Elbow Wrap, designed to offer muscle relief, could pose a risk of burn injuries, the Australian Competition and Consumer Commission (ACCC) said in its recall issued on Tuesday. The rechargeable heat pad could overheat if incorrectly positioned or wrapped too tightly. Injuries have occurred, the notice continued. Anyone who purchased the product from Kmart or Target between January 1 and April 4 has been urged to 'stop using it immediately.' Customers can return the product for a full refund. Kmart issued a statement on social media. 'We take the quality and safety of our products very seriously,' the company said. 'We would like to advise you of a product safety recall.' Anyone who bought the product as a gift for someone has been urged by the ACCC to contact the store. If returning the product is not possible, customers should contact Kmart on 1800 124 125 or Target on 1300 753 567 for further information.
